![Show Menu](styles/mobile-menu.png)
![Page Background](./../common/page-substrates/page0038.png)
38
43.
Reid IR, Nicholson GC, Weinstein RS, Hosking
DJ, Cundy T, Kotowicz MA, et al. Biochemical
and radiologic improvement in Paget's disease
of bone treated with alendronate: a randomized,
placebo-controlled
trial.
Am
J
Med.
1996;101:341-8.
44.
Miller PD, Brown JP, Siris ES, Hoseyni MS,
Axelrod DW, Bekker PJ. A randomized, double-
blind comparison of risedronate and etidronate
in the treatment of Paget's disease of bone.
Paget's Risedronate/Etidronate Study Group.
Am J Med 1999;106:513-20.
45.
Miller PD, Brown JP, Siris ES. A randomized,
double-blind comparison of risedronate and
etidronate in the treatment of Paget's disease of
bone. Paget's Risedronate/Etidronate Study
Group. Am J Med. 1999;106:513.
46.
Merlotti D, Gennari L, Martini G. Comparison
of different intravenous bisphosphonate
regimens for Paget's disease of bone. J Bone
Miner Res 2007;22:1510.
47.
Walsh JP, Ward LC, Stewart GO, Will RK,
Criddle RA. A randomized clinical trial
comparing oral alendronate and intravenous
pamidronate for the treatment of Paget's disease
of bone. Bone 2004;34:747.
48.
Reid IR, Miller P, Lyles K. Comparison of a
single infusion of zoledronic acid with